| Bioactivity | BI-1935 is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease[1]. | ||||||||||||
| Target | sEH | ||||||||||||
| Name | BI-1935 | ||||||||||||
| CAS | 940954-41-6 | ||||||||||||
| Formula | C24H21F3N6O3 | ||||||||||||
| Molar Mass | 498.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Roman Wolfgang Fleck, et al. Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors. WO2007067836A2. |
BI-1935
CAS: 940954-41-6 F: C24H21F3N6O3 W: 498.46
BI-1935 is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular di
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.